Cite
HARVARD Citation
Borazanci, E. et al. (2020). A Phase Ib Study of Single‐Agent Idelalisib Followed by Idelalisib in Combination with Chemotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma. Oncologist. pp. e1604-e1613. [Online].